PBYI

Conviction 100HealthcareScan · Mon, Aug 10, 2026

PBYI$8.70-2.36%

ResistanceSupportVol 14Insider sell

Vol MA14 359.68K

May 11May 28Jun 16Jul 6Jul 23Aug 10

PUMA BIOTECHNOLOGY, INC.PHARMACEUTICAL PREPARATIONSwww.pumabiotechnology.com ↗

Price8.70

Change-2.36%

Gap+0.22%

Rel volume2.78×

Avg volume364.27K

Avg $ vol3.01M

SMA 208.16

SMA 507.80

SMA 2006.68

Price vs 50+11.52%

Price vs 200+30.25%

MA stackbullish

50/200 cross—

Supertrendup · 7.46

RSI (14)62

MACD hist0.06

MACD crossbull · 1d

Stoch %K / %D65 / 64

ADX (14)22

+DI / −DI33 / 16

RSI divergenceBearish

MACD divergenceBearish

ATR %+4.80%

ADR %4.99%

52w high8.91

52w low3.69

From 52w high-2.36%

Above 52w low+135.77%

New 52w highNo

SqueezeOff

Bollinger width16.09%

%B0.91

Donchian pos64.83%

Donchian high9.40

Donchian low7.41

AVWAP (52w high)8.77

vs AVWAP high-0.82%

AVWAP (52w low)6.03

vs AVWAP low+44.23%

OBV trendFlat

Chaikin MF (20)0.04

Today vs 20d2.78×

Avg vol (14d)359.68K

Avg vol (20d)364.27K

Avg $ vol (20d)3.01M

Market cap—

RS 3m (vs SPY)+17.03%

RS 6m (vs SPY)+17.11%

RS line new highYes

Trend template8/8

Technical rank86.5

1 week+13.13%

1 month+8.75%

3 months+16.15%

6 months+25.36%

1 year+164.44%

YTD+50.78%

P/E14.85

P/B3.33

P/S2.02

P/FCF11.07

EPS0.6100

Div yield—

ROE22.46%

ROA16.14%

Debt/Eq0.00

Current2.91

EV/EBITDA8.82

Gross margin—

Net margin13.62%

Rev growth-0.91%

EPS growth2.75%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value425.46M

Revenue56.5M

Net income8.19M

Gross profit—

Free cash flow41.73M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees179

ListedWed, Mar 21, 2012

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank86.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.71

Support7.19

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 5
1 scan
→
Breaking out now
Jun 8
1 scan
→
Setting up
Jun 9
1 scan
→
Breaking out now
Jun 10 – Jun 11
2 scans
→
Broke out
Jun 12
1 scan
→
Setting up
Jul 13 – Jul 15
2 scans

Congress activity

Disclosed STOCK Act trades in PBYI

All disclosures →

No recent disclosed trades by Congress in PBYI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PBYI · 3 sells

Insider	Side	Shares	Value	Traded	Filed
AUERBACH ALAN H President and CEO · Common Stock · 2026-07-06	Sell	44.06K	$364K	2026-07-06	2026-07-08
HUNT DOUGLAS M See Remarks · Common Stock · 2026-07-06	Sell	8.46K	$70K	2026-07-06	2026-07-08
NOUGUES MAXIMO F Chief Financial Officer · Common Stock · 2026-07-06	Sell	9.39K	$78K	2026-07-06	2026-07-08

SEC filings

EDGAR filings in PBYI · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.